共 50 条
- [41] Multiple infliximab biosimilar switches appear to be safe and effective in a real-world inflammatory bowel disease cohort JOURNAL OF CROHNS & COLITIS, 2023, 17 : 876 - 876
- [42] Facing Real-World Challenges of Immunogenicity in Pediatric Inflammatory Bowel Disease FRONTIERS IN IMMUNOLOGY, 2020, 11
- [43] A Real-World Picture of Adverse Drug Reactions in Inflammatory Bowel Disease JOURNAL OF CROHNS & COLITIS, 2022, 16 : I436 - I436
- [44] A Real-World Picture of Adverse Drug Reactions in Inflammatory Bowel Disease JOURNAL OF CROHNS & COLITIS, 2022, 16 : I436 - I436
- [45] Real-World Outcomes of Dual Advanced Therapy in Inflammatory Bowel Disease AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (12S): : S4 - S4
- [46] Infliximab Biosimilar Use for Inflammatory Bowel Disease: A National Veterans Affairs Experience AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S389 - S390